Find and Pitch Jounalists, Get Your Story Covered

Tags: clozapine schizophrenia touch neutropenia mental illness

	Profile	Recent Articles on Subject
1	Kristen Monaco MedPage Today	Most Clozapine Prescribers Satisfied With REMS Program - 19 days ago Imcivree Label Expanded; Weight Loss With Weekly Injection; Kidney Donation Chain - 2 months ago FDA Approves First-Ever Drug for Serious Liver Condition - 12 months ago
2	Shannon Firth MedPage Today Washington correspondent for MedPageToday. CUNYJschool pride. Healthcarejournalism	Ozempic/Wegovy and 14 Other Drugs Selected for Medicare Price Negotiation - about 2 months ago
3	John Pinching PharmaTimes Next-gen biopharma company. La Jolla, California biopharmadrugsdevices	Pheno Therapeutics granted trial authorisation for MS candidate - about 2 months ago NICE endorses Neuraxpharm’s ublituximab for treating MS - 3 months ago
4	Greg Laub MedPage Today Director of Video at MedPage Today. Screenwriter, previous managing editor. videographyscreenwritingediting	Integrating MRD in Myeloma: Guidance for Therapy Escalation and De-escalation - 2 months ago Belantamab Mafodotin: The Comeback Drug in Multiple Myeloma - 8 months ago A Novel Mechanism of Action in Treating Relapsing MS - over 1 year ago New Data on CD40 Ligand Inhibitor for Relapsing MS - over 1 year ago Targeting Chronic Inflammation in Progressive MS - over 1 year ago Multiple Sclerosis: Treat Early With High-Efficacy Therapy - over 1 year ago Multiple Sclerosis: Paving the Way to a Cure - over 1 year ago MS Treatment-Discontinuation Study Terminated After Disease Activity Returns - over 1 year ago
5	Michael Gibney Pharma Voice Teacher of English. Teacher of politics. Santiago, Chile educationpolitics	Regeneron’s R&D approach scores dual wins against Alexion’s Ultomiris and in lymphoma - 3 months ago GSK’s multiple myeloma ADC Blenrep was pulled from the market. Now, it’s poised for a comeback. - 3 months ago
6	Judy George MedPage Today Medical reporter, writer. Medical reportingartsliterature	Alzheimer's Data Withdrawn - 4 months ago
7	Susan Kelly MedTech Dive Leader, teacher, learner. St. John's youthtech sector	Medtronic, Recor win CMS transitional payment coverage for renal denervation devices - 4 months ago
8	Ed Silverman STAT News Pharmalot columnist. Senior writer at STATnews. pharmaceutical industry	STAT+: Pharmalittle: We’re reading about a Merck drug-label controversy, Astellas pulling an application, and more - 4 months ago STAT+: Pharmalittle: We’re reading about Boehringer biosimilar frustrations, FTC warnings, and more - 11 months ago STAT+: Pharmalittle: We’re reading about a liver-drug approval, pharma’s positive outlook, and more - 12 months ago STAT+: Pharmalittle: U.S. to impose inflation penalties on dozens of drugmakers; Supreme Court will decide abortion pill access - about 1 year ago STAT+: Pharmalittle: Sanofi scraps rare-disease drug deal under FTC pressure; patients regain weight after stopping Lilly’s Zepbound - about 1 year ago STAT+: Pharmalittle: German regulator eyes Ozempic export ban amid shortages; NIH-funded clinical trials lagging pharma’s in enrollment - over 1 year ago STAT+: Pharmalittle: Eisai reports injectable version of Alzheimer’s drug as effective as IV; Pfizer says combo flu and Covid shot shows strong response - over 1 year ago STAT+: Pharmalittle: FDA panel lacks confidence in Amgen cancer drug data; weight loss drugs linked to rare stomach problems - over 1 year ago
9	Nick Paul Taylor MedTech Dive Top 5 Mario Kart Player. Gaming	European Parliament calls for proposals to reform MDR and IVDR by end of Q1 - 4 months ago EMA updates advice on drug-device combinations under MDR, IVDR - 10 months ago FDA hits Renovo with warning letter over reprocessed medical devices - 11 months ago
10	Jonathan Wosen STAT News West Coast Biotech Reporter. Formerly @sdut. Stanford PhD. UCSC alum. San Diego, California BiotechLife SciencesImmunology	STAT+: FDA approves Roche’s injectable version of blockbuster multiple sclerosis drug - 6 months ago STAT+: Pharmalittle: End of biotech’s stock market malaise may be near; cancer drug shortages hit rural clinics hard - over 1 year ago

Journalists covering REMS